Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.

Authors
Publication date
5 July 2012
Publisher
eScholarship, University of California

Abstract

Docetaxel and irinotecan chemotherapy have shown good efficacy in the treatment of advanced oesophago-gastric cancer. This randomised phase II study evaluated the efficacy and toxicity profile of two non-platinum docetaxel-based doublet regimens in advanc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Sustaining member

    eScholarship - University of California

    redirect
    oaioai:escholarship.org:ark:/1303...
    Last time updated on 25/12/2021